BIO-TOX
21987
BIO-Tox LABORATORIES
Laboratory Director Toxicologist Toxicologist
Erin Crabtrey, M.S., D-ABFT-FT Ola Bawardi, M.S. Kristen Steward, M.S., D-ABFT-FT May 15, 2024
RE: Pricing Adjustments Effective for Samples received July 1, 2024 Dear Valued Customer and Accounts Payable Department,
At Bio-Tox Laboratories, we remain dedicated to providing the highest level of toxicology services to our customers in Riverside, San Bernardino, and San Diego counties. We greatly appreciate your continued support and the trust you have placed in us as your toxicology lab since 1987. It is our goal to consistently deliver reliable and defensible toxicology results, and we value the importance you attribute to our contribution.
We continue to encounter higher costs due to various factors in this post-pandemic world and the prevailing economic environment. In addition to increased energy prices, supplier costs, logistics expenses, equipment investments, and other critical components necessary for testing, our latest accreditation process with ANAB and ISO/IEC 17025:2017 has impacted our business greatly.
Additional quality control and management of every aspect of our laboratory in order to maintain this accreditation take time, consistency and continuous monitoring of the utmost degree. These requirements continue to add additional levels of expense throughout every aspect of our business. While we continue to focus on productivity and efficiency improvements, these efforts alone are not enough to absorb the rising costs associated with daily business operations. Consequently, we find it necessary to adjust the prices of some of our toxicology services for samples received starting from July 1, 2024.
Our latest 13 Panel Drug Screen remains the primary drug screening option for DUl cases. In addition to the drug categories included in our 10 Panel Drug Screen (Amphetamines, Cocaine, PCP, Benzodiazepines, Opiates, Cannabinoids, Carisoprodol (Soma), Fentanyl, Oxycodone, and Zolpidem (Ambien)), we have incorporated three additional drugs: Buprenorphine, Methadone, and Tramadol. These drugs are recognized by the toxicology community as being relevant to the increasing abuse of prescription drugs. By expanding the drug panel, we offer broader screening capabilities at a reasonable price. We strongly recommend the 13 Panel Drug Screen for all driving cases, and we kindly request that you remind your officers of this valuable option and encourage them to request it on the chain of custody envelope for their DUl cases.
To stay up to date with the drugs prevalent in our communities, we continue to augment our benzodiazepine panel and comprehensive panel. Furthermore, we are pleased to announce the addition of sodium fluoride testing to our alcohol analysis for DUl alcohol cases when requested
We kindly request that you share this notice with the appropriate personnel at your agency as soon as possible to ensure they are aware of the upcoming price changes. If you have any questions or require further clarification regarding the fee increases, please do not hesitate to contact our office. Melissa and I can be reached at (951) 341-9355.
Thank you once again for your continued partnership and trust in Bio-Tox Laboratories. We look forward to serving you with the same level of professionalism and commitment that you have come to expect from us.
Sincerely,
Tracey Stangarone
Business Manager
Mailing Address: P.O. Box 52695 • Riverside, California 92517 • 951/341-9355 • FAX 951/341-9359
RIALTO POLICE DEPARTMENT PRICING SCHEDULE
July 1, 2024 through June 30, 2025
Unit
Test Description Charge
6-Panel Drug Screen* $ 56.00
(Includes Methamphetamine, Cocaine, Morphine/Codeine, PCP, Benzodiazepines, and Cannabinoids)
10-Panel Drug Screen* $ 86.00
(Includes 6-Panel Drug Screen plus Carisoprodol, Fentanyl, Oxycodone and Zolpidem)
-- - -$110:00
13-Panel Drug Screen*
(Includes 10-Panel Drug Screen plus Buprenorphine, Methadone and Tramadol) Alcohol Analysis, Title 17 $125.00
Benzodiazepines Panel with Quantitation $225.00
Comprehensive Drug Screen Panel* $230.00
(Drug screen to include over 200 prescription drugs)
GHB $230.00
Quantitative Confirmation by LC/MS/MS, per drug class $145.00 (Includes Amphetamines, Cannabinoids, Cocaine, PCP, Opiates) Other Drugs by LC/MS/MS $155.00
(Some may be slightly higher)
Biohazard Waste Fee, Per Sample $ 1.00
Chain of Custody Fee (Per Sample not Tested) $ 25.00
Leaking Sample $ 35.00
Name Discrepancy $ 35.00
Report Corrections (Agency request) $ 45.00
Sample Return $ 35.00
*All positive drugs screens will be confirmed by LC/MS/MS.
Drugs listed in panels may change based on laboratory discretion.